The order of hormonal interventions can be a research question in its own right. This trial investigated a preparatory FSH phase before subsequent fertility induction. Primary study
What was compared
Men with congenital hypogonadotropic hypogonadism and very small testes were randomized in an open-label study to pulsatile GnRH alone or recombinant FSH pretreatment followed by GnRH. Sperm appeared in seven of seven men in the pretreatment group and four of six in the comparison group. The study also examined testicular growth, hormones, and tissue development. Primary report
Our appraisal: a sequence comparison is not a universal protocol
The biological rationale for preparing one cell population before stimulating later development is plausible, but plausibility does not substitute for precise outcome estimates. With very small groups, one participant's result can substantially change the apparent success rate.
The trial population was deliberately narrow. Baseline testicular development, prior treatment, and exclusion criteria affect applicability. Findings should not be transferred automatically to men with different causes of infertility or normal gonadotropin function.
The later intervention was pulsatile GnRH. This detail should remain explicit rather than silently replacing it with hCG because both appear in related clinical discussions. A sequence tested with one subsequent treatment is not direct evidence for every alternative sequence.
Sperm appearance is a meaningful step, but it differs from achieving a specified concentration, conception, or live birth. A claim of fertility restoration should identify which of those endpoints was actually demonstrated.
This trial provides a focused randomized signal about developmental preparation in a selected endocrine disorder. It does not establish that everyone should receive FSH first or that the observed proportions are reliable individual predictions. Review should inspect enrollment flow, group balance, confidence intervals, and prespecified endpoints before converting a promising small-study pattern into a broad comparative claim.
Frequently asked questions
Was treatment randomized?
Yes, in an open-label design.
What followed FSH pretreatment?
Pulsatile GnRH.
Were the groups large?
No; the reported sperm-outcome groups contained seven and six men.
Does sperm appearance equal live birth?
No.
Can this be generalized to all male infertility?
No.
Does this directly test every hCG-based sequence?
No.
What is the key research question?
Whether a preparatory phase changes later fertility-induction outcomes in a selected population.